3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): pharmacology and toxicology in animals and humans.
about
Nephrotoxic effects of common and emerging drugs of abuse.Mephedrone, an abused psychoactive component of 'bath salts' and methamphetamine congener, does not cause neurotoxicity to dopamine nerve endings of the striatumComparison of (+)-(11)C-McN5652 and (11)C-DASB as serotonin transporter radioligands under various experimental conditionsLabelled alpha-methyl-L-tryptophan as a tracer for the study of the brain serotonergic systemA study of the mechanisms involved in the neurotoxic action of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') on dopamine neurones in mouse brainSustained effects of ecstasy on the human brain: a prospective neuroimaging study in novel users.Synthetic studies and pharmacological evaluations on the MDMA ('Ecstasy') antagonist nantenine.Electrical coupling between the human serotonin transporter and voltage-gated Ca(2+) channels.Neurological complications of drug abuse: pathophysiological mechanisms."Saturday night fever": ecstasy related problems in a London accident and emergency department.Human psychobiology of MDMA or 'Ecstasy': an overview of 25 years of empirical research.Cognitive performance in recreational users of MDMA of 'ecstasy': evidence for memory deficits.A comprehensive review of MDMA and GHB: two common club drugs.A Caenorhabditis elegans p38 MAP kinase pathway mutant protects from dopamine, methamphetamine, and MDMA toxicity.3,4-methylenedioxyamphetamine upregulates p75 neurotrophin receptor protein expression in the rat brain.Direct comparison of (+/-) 3,4-methylenedioxymethamphetamine ("ecstasy") disposition and metabolism in squirrel monkeys and humans.Hydrolysis of 3,4-methylenedioxymethamphetamine (MDMA) metabolite conjugates in human, squirrel monkey, and rat plasma.Causes and consequences of methamphetamine and MDMA toxicity.Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or Ecstasy.Bench-to-bedside review: mechanisms and management of hyperthermia due to toxicityStudies of (±)-3,4-methylenedioxymethamphetamine (MDMA) metabolism and disposition in rats and mice: relationship to neuroprotection and neurotoxicity profileAlcohol Interactions with Psychostimulants: An Overview of Animal and Human Studies.Simultaneous liquid chromatographic-electrospray ionization mass spectrometric quantification of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) and its metabolites 3,4-dihydroxymethamphetamine, 4-hydroxy-3-methoxymethamphetamine and 3,4-methyleneChronic unpredictable stress augments +3,4-methylenedioxymethamphetamine-induced monoamine depletions: the role of corticosteroneValidated liquid chromatographic-electrospray ionization mass spectrometric assay for simultaneous determination of 3,4-methylenedioxymethamphetamine and its metabolites 3,4-methylenedioxyamphetamine, 3,4-dihydroxymethamphetamine, and 4-hydroxy-3-mePositron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (+/-)3,4-methylenedioxymethamphetamine ("ecstasy") users: relationship to cognitive performance.MDMA decreases the effects of simulated social rejection.Psychiatric disorders and their correlates among young adult MDMA users in Ohio.MDMA toxicity: no evidence for a major influence of metabolic genotype at CYP2D6.Ecstasy intoxication: the toxicological basis for treatment.Studies on the role of dopamine in the degeneration of 5-HT nerve endings in the brain of Dark Agouti rats following 3,4-methylenedioxymethamphetamine (MDMA or 'ecstasy') administration.Arginine vasopressin release in response to the administration of 3,4-methylenedioxymethamphetamine ("ecstasy"): is metabolism a contributory factor?Studies, using in vivo microdialysis, on the effect of the dopamine uptake inhibitor GBR 12909 on 3,4-methylenedioxymethamphetamine ('ecstasy')-induced dopamine release and free radical formation in the mouse striatum.Ecstasy use in South Africa: findings from the South African Community Epidemiology Network on Drug Use (SACENDU) project (January 1997-December 2001).Acute effects of 3,4-methylenedioxymethamphetamine (MDMA) on behavioral measures of impulsivity: alone and in combination with alcohol.Elevated impulsivity and impaired decision-making in abstinent Ecstasy (MDMA) users compared to polydrug and drug-naïve controls.Morbidity associated with MDMA (ecstasy) abuse: a survey of emergency department admissions.The effect of catecholamine depletion by alpha-methyl-para-tyrosine on measures of cognitive performance and sleep in abstinent MDMA users.Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users.Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity.
P2860
Q21558458-1B291433-347B-4A6C-B0D3-925136C472D3Q24621938-71AF29AE-A8FC-4C2C-91B4-B26222B8E5D1Q24677228-D15B7CD0-1C73-4D96-B09B-FFD7B88AD0B4Q28361167-33CCD4A9-6CC6-4EAA-ADC7-9611AA70F0EBQ28366048-49AF6705-6F64-4A42-9DFF-0CF4FA075293Q33374696-610642F2-9CBD-4CF4-89BE-189C71E6AB59Q33638199-E110439F-1D43-47DF-934E-FB2542175727Q33736971-6B455858-5522-4FE3-82CF-540993873CF8Q34117191-3C5AA07A-C2E0-41B3-B112-B47FB00AA2B8Q34292882-35CC514F-D905-4B49-89D1-3E0329F0AAF1Q34359604-5E1270D8-80AD-4D10-8EF7-DE6022BE47C7Q34467867-8D67AB96-4882-4459-BB00-0377A56B5143Q34476901-817373D7-EB97-4A40-A983-807251FD9538Q35058866-84EC6374-1A2E-4E48-AAD8-5845F8F59181Q35123814-2833DE0E-5A41-44FD-9D1F-A09FFBE912D6Q35176011-187D6EEB-A89E-4E6E-B9FD-F8625E127636Q35184723-E0DF174D-CEF7-4CD8-8DD7-714077739C5DQ35594881-134F67BB-F400-44F4-B080-BB4BE717F28FQ36020276-554EBF61-3BE2-4113-938B-659383FB544CQ36465395-DB8A1FB8-3A0D-4D50-866F-C56231361FDCQ36573258-D1307134-9391-4390-AE6E-9814F74DEF06Q37138642-6FCA36E6-F97F-444D-B6C8-97FFF58BE3E4Q37161392-0FB753CF-D222-4EFF-B04B-9F5059F4D17EQ37180812-F1F9943C-A7F1-4F72-B43F-576883C7F4A7Q37193466-2789FADB-6D4D-4847-9C91-F47CEE7F4243Q37461894-F9781462-136C-4E9A-877A-6940ABD19036Q37542856-BEFACAA5-029E-4154-BE08-2B648C3E0412Q39754329-965C0E63-CFBD-483E-B5BF-77F7A250BE39Q40140901-E4374AC9-BA59-40C6-A2A2-31F80F0AAFA9Q40540791-18BEE2F8-903F-44E9-B05F-A4E0CE58AF0CQ42008895-E11401AD-C5F4-4449-A2C7-E5265CD7CDB5Q43791430-C555C64C-6587-4397-B3D6-396925B9EF5CQ44028686-7737541C-4707-4BFB-B1CA-1EF0E6744CFEQ44787677-D1F2736E-C76D-453A-9966-502C827035F5Q46701574-BF0DF54A-AEFF-4393-82DE-139249577F63Q46808071-06FF4891-70A1-43C3-8BA3-5D643158E6ADQ48190928-00A9775E-21F8-4A92-9329-E98F610C8A27Q48319552-118D164D-CDD3-4646-8E72-7582AD097595Q48598861-F15E24E2-476B-4AE5-AF49-0644B28C2F3CQ51094956-7A8A61E5-446D-4FBC-B506-85B68EFEA465
P2860
3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): pharmacology and toxicology in animals and humans.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
3,4-Methylenedioxymethamphetam ...... icology in animals and humans.
@en
type
label
3,4-Methylenedioxymethamphetam ...... icology in animals and humans.
@en
prefLabel
3,4-Methylenedioxymethamphetam ...... icology in animals and humans.
@en
P2093
P2860
P1433
P1476
3,4-Methylenedioxymethamphetam ...... icology in animals and humans.
@en
P2093
P2860
P304
P356
10.1111/J.1360-0443.1994.TB03330.X
P407
P577
1994-05-01T00:00:00Z